Gitlin Michael J
Department of Psychiatry, Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Int J Bipolar Disord. 2018 Dec 1;6(1):25. doi: 10.1186/s40345-018-0133-9.
The proper place and the optimal use of antidepressants in treating bipolar depression continues to be an area of great interest and greater controversy with passionate opinions more common than good studies. Even the handful of meta-analyses in the area disagree with each other. Overall, the evidence that antidepressants are effective in treating bipolar depression is weak. Additionally, many experts and clinicians worry greatly about the capacity of antidepressants to cause affective switching or mood destabilization. Yet, in short term controlled studies, with most patients also taking mood stabilizers, antidepressants are not associated with switches into mania/hypomania. Evidence of cycle acceleration with antidepressants primarily reflects treatment with older antidepressants, e.g., tricyclics. Similar evidence with modern antidepressants such as selective serotonin reuptake inhibitors (SSRIs) is lacking. The key questions should not be: are antidepressants effective in bipolar depression?; And: do antidepressants worsen the course of bipolar disorder? Rather, the question should be focused on subgroups: for which patients are antidepressants helpful and safe, and for which patients will they be harmful? Predictors of affective switching with antidepressants include: bipolar I disorder (vs. bipolar II), mixed features during depression, tricyclics vs. modern antidepressants, rapid cycling and possibly a history of drug abuse, especially stimulant abuse. Additionally, a number of recent studies have demonstrated both the safety and efficacy of antidepressant monotherapy in treating bipolar II depression. Finally, a subgroup of bipolar individuals need antidepressants in addition to mood stabilizers as part of an optimal maintenance treatment regimen.
抗抑郁药在双相抑郁治疗中的合理应用场所及最佳用法仍是一个备受关注且争议颇大的领域,充满激情的观点远比高质量研究更为常见。即便该领域为数不多的荟萃分析彼此之间也存在分歧。总体而言,抗抑郁药治疗双相抑郁有效的证据较为薄弱。此外,许多专家和临床医生极为担忧抗抑郁药引发情感转换或情绪不稳定的能力。然而,在短期对照研究中,大多数患者同时服用心境稳定剂,抗抑郁药与转换为躁狂/轻躁狂并无关联。抗抑郁药导致发作周期加速的证据主要反映的是使用如三环类等较老一代抗抑郁药的治疗情况。缺乏使用如选择性5-羟色胺再摄取抑制剂(SSRI)等现代抗抑郁药的类似证据。关键问题不应是:抗抑郁药对双相抑郁有效吗?以及:抗抑郁药会使双相情感障碍的病程恶化吗?相反,问题应聚焦于亚组:抗抑郁药对哪些患者有益且安全,对哪些患者有害?抗抑郁药引发情感转换的预测因素包括:双相I型障碍(相对于双相II型)、抑郁发作时的混合特征、三环类药物与现代抗抑郁药、快速循环发作以及可能存在的药物滥用史,尤其是兴奋剂滥用史。此外,近期的多项研究已证实抗抑郁药单药治疗双相II型抑郁的安全性和有效性。最后,作为最佳维持治疗方案的一部分,有一部分双相情感障碍患者除了需要心境稳定剂外,还需要抗抑郁药。